Company |
Drug |
Indication |
Baxalta Inc. (Bannockburn, Ill.) |
Adynovate |
Hemophilia A |
Collegium Pharmaceutical Inc. (Canton, Mass.) |
Xtampza ER |
Pain |
Cumberland Pharmaceuticals Inc. (Nashville, Tenn.) |
Caldolor |
Pain and reduction of fever |
Emergent Biosolutions Inc. (Gaithersburg, Md.) |
Biothrax |
Preventing disease following suspected or confirmed exposure to Bacillus anthracis |
Genentech Inc. (South San Francisco) and Exelixis Inc. (South San Francisco) |
Cotellic |
Locally advanced or metastatic melanoma |
Genmab A/S (Copenhagen) |
Darzalex |
Multiple myeloma |
Gilead Sciences Inc. (Foster City, Calif.) |
Genvoya |
HIV |
Gilead Sciences Inc. (Foster City, Calif.) |
Harvoni |
Hepatitis C virus and HIV |
Lightlake Therapeutics Inc. (New York) |
Narcan |
Opioid overdose |